Eberhard Grube, MD: negative late loss with drug eluting stents
Eberhard Grube, MD, Chief of Cardiology at the Seigburg Heart center in Germany, discusses the problems of negative late loss caused by drug eluting stents with a durable polymer coating (Taxus, Cypher).
Question: Do you believe the new Xience, Promus or Endeavor stents also cause malaposition? Is Plavix, prasugrel (Effient) or other anticoagulation still required with the next-generation DES? Post your comments.
Cardiac surgery, Cardiology, Cardiology/interventional, Siegburg Heart | apples49 | 
April 17, 2009 5:17 pm
No Comments
No comments yet.
Notice: comments_rss_link is deprecated since version 2.5! Use post_comments_feed_link() instead. in /data/30/1/121/80/1121895/user/1185656/htdocs/wordpress/wp-includes/functions.php on line 3406
RSS feed for comments on this post.
TrackBack URI
